Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Dianthus Therapeutics, Inc.

NASDAQ: DNTH · Life Sciences · 4 alerts · CIK 1690585

Share price
$89.55Close, Nov 16
Market cap
$5.04B
Shares outstanding
56.31MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Dianthus Therapeutics, Inc. filings on SEC EDGAR ↗

5:32 PM ET Form 4
Insider Selling

Dianthus Therapeutics EVP, CFO & Cbo Ryan Savitz Sells $11.2M of Stock

Ryan Savitz, EVP, CFO & Cbo, sold 124,042 shares of Dianthus Therapeutics, Inc. at $85.16 to $91.59 a share (average $90.52) in 9 transactions, worth $11.2M in total between Nov 9, 2026 and Nov 12, 2026. Shares held after the trade: 0 (-100.0%).

Value
$11.2M
Shares
124,042
Average price
$90.52
Role
EVP, CFO & Cbo
Holding change
-100.0%
Trade date
Nov 9, 2026 to Nov 12, 2026
4:36 PM ET Form 4
Insider Selling

Dianthus Therapeutics CAO Edward Carr Sells $2.03M of Stock

Edward Carr, CAO, sold 20,000 shares of Dianthus Therapeutics, Inc. at $100.43 to $104.39 a share (average $101.38) in 5 transactions, worth $2.03M in total on Sep 17, 2026. Shares held after the trade: 0 (-100.0%).

Value
$2.03M
Shares
20,000
Average price
$101.38
Role
CAO
Holding change
-100.0%
Trade date
Sep 17, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.